Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphocytic Leukemia (ALL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00846703
What this trial is testing

The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Sun Yat-sen University 600
Testing effectiveness (Phase 2)Ended earlyNCT03743246
What this trial is testing

Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma, Non-Hodgkin
Celgene 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643103
What this trial is testing

Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial

Who this might be right for
Ph- Acute Lymphoblastic Leukemia (Ph-ALL)
Institute of Hematology & Blood Diseases Hospital, China 32
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00021242
What this trial is testing

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 12
Large-scale testing (Phase 3)Study completedNCT00002812
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 2,078
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Not applicableUnknownNCT01272440
What this trial is testing

A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia

Who this might be right for
Acute Lymphoblastic Leukaemia
Aarhus University Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03301168
What this trial is testing

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+6 more
Bellicum Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT00337168
What this trial is testing

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 36
Testing effectiveness (Phase 2)Looking for participantsNCT06481735
What this trial is testing

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Who this might be right for
Acute Lymphocytic Leukemia
Chinese PLA General Hospital 30
Not applicableStudy completedNCT05565040
What this trial is testing

Concealed Penis in Pediatric Age Group

Who this might be right for
Pediatric ALLSurgeryUrologic Diseases
Egyptian Biomedical Research Network 150
Early research (Phase 1)UnknownNCT03574168
What this trial is testing

CD19-CAR-T Cells in Patients With R/R B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Bioceltech Therapeutics, Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03960840
What this trial is testing

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaDiffuse Large B-cell Lymphoma+2 more
Novartis Pharmaceuticals 217
Early research (Phase 1)Active Not RecruitingNCT04732845
What this trial is testing

Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia
Benjamin Tomlinson 18
Early research (Phase 1)Study completedNCT01396499
What this trial is testing

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT03544021
What this trial is testing

CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）

Who this might be right for
Leukemia, Lymphocytic, Acute
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Testing effectiveness (Phase 2)Looking for participantsNCT06387121
What this trial is testing

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Early research (Phase 1)Study completedNCT00498316
What this trial is testing

Cord Blood Expansion on Mesenchymal Stem Cells

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 98
Large-scale testing (Phase 3)Study completedNCT00186901
What this trial is testing

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

Who this might be right for
Leukemia, Lymphoblastic, AcuteOsteoporosis
St. Jude Children's Research Hospital 429
Next Page